Thyroid medications recalled due to risk of impurities

Story highlights

  • Westminster Pharmaceuticals has recalled some of its medications
  • Customers using the pills should check with their doctor or pharmacist

The medication in question contains a combination of levothyroxine, called LT4, along with liothyronine, called LT3. Both are synthetic thyroid hormones used when a person’s thyroid gland can be no longer functioning properly.

“While we stand behind the quality of our product, we are taking the utmost precaution by recalling our Thyroid, USP Tablets only to the wholesale level due to a recent inspection by the FDA at one of our active ingredient manufacturers,” Westminster Pharmaceuticals owner along with CEO Gajan Mahendiran said in a statement.
FDA expands recall of blood pressure drug valsartan due to cancer concern
The FDA inspected the Sichuan Friendly Pharmaceutical Co.’s manufacturing plant in October. In a letter dated June 22, the agency informed the Chinese company that will the plant was not meeting its not bad manufacturing process standards. If the company fails to correct those issues, the letter warned, that will could “result in FDA continuing to refuse admission of articles manufactured.”

No adverse effects through these medications had been reported as of August 9, Westminster Pharmaceuticals said; instead, the lots were being recalled out of an abundance of caution.

Because thyroid medications can treat serious disease, the FDA recommends that will consumers continue to take the pills until they can contact their physician or pharmacist for further guidance.

The recall affects 37 unexpired lots of levothyroxine along with liothyronine (Thyroid Tablets, USP) 15, 30, 60, 0 along with 0 milligrams. The company can be reaching out to all wholesale customers to ask them to stop filling prescriptions with the affected pills, which are sold in 100-count bottles.

Details on the specific lots along with product descriptions can be found on the FDA website.

Consumers with questions about the recall can contact Westminster’s Regulatory Affairs Department on weekdays at 888-354-9939 or email

Source : Thyroid medications recalled due to risk of impurities